Latest News & Features
article
Counsel for Ventria sat down with Sarah Speight to explore their landmark win at the International Trade Commission, which led to a US ban for a Chinese company 3 November 2022
article
Patent law firm EIP has hired Pontus Falk as a partner at its recently opened Sweden office. 3 November 2022
Big Pharma
Cardiovascular ‘innovator’ snapped up as company strengthens medtech offering | Massachusetts-based Abiomed will become part of purchaser’s medtech division 2 November 2022
Generics
Agreement is 'first ever' public health focused voluntary licensing deal on a cancer medicine| Opportunities for generic manufacturers 1 November 2022
Big Pharma
The temporary injunction prevents a Pfizer unit from launching a generic| The dispute centres on a branded coronary artery test 1 November 2022
article
Recent Federal Circuit decisions have sown confusion among patent practitioners regarding core aspects of US patent law, including induced infringement, patent eligibility, written description, and enablement. Although the Supreme Court recently declined to provide needed clarity on patent eligibility in American Axle, it still has several opportunities in the coming months to address other critical issues for the LSPN community. 1 November 2022
Biotechnology
Developments in microbiome tech are aimed at reducing the need for antibiotics in livestock farming and have led to some notable patenting trends and requirements, explains Rosie McDowell of EIP. 27 October 2022
Generics
The probe in Spain centred on the delayed entry of generic versions of a branded contraceptive | The commission found evidence of “unjustified legal action”. 26 October 2022
article
The firm has strengthened its Sheffield office with a senior patent attorney who joins from GlaxoSmithKline. 25 October 2022
Big Pharma
The deal sees Sumitomo acquiring ownership of cancer and uterine fibroid treatments | Myovant initially rejected low offer that “undervalued” the company. 25 October 2022